Sysmex Corp. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
41,469
55,925
57,096
58,472
61,627
51,319
Total Accounts Receivable
44,626
52,464
62,205
66,851
77,595
90,709
Inventories
27,318
29,887
36,226
37,575
41,684
40,231
Other Current Assets
12,410
15,872
2,724
3,416
4,041
5,783
Total Current Assets
125,823
154,148
158,258
166,318
184,952
195,423
Net Property, Plant & Equipment
53,774
59,061
59,282
60,144
67,651
76,312
Total Investments and Advances
4,669
7,171
9,446
8,061
7,897
7,684
Long-Term Note Receivable
13
11
6,476
8,813
10,882
12,202
Intangible Assets
23,858
23,783
23,603
29,536
42,016
44,954
Other Assets
2,489
3,542
1,163
1,359
3,144
4,373
Total Assets
210,758
247,983
263,917
279,817
321,979
346,775
ST Debt & Current Portion LT Debt
1,107
50
149
170
180
Accounts Payable
13,263
15,965
19,873
17,661
21,579
Income Tax Payable
7,707
9,740
6,511
2,915
7,717
Other Current Liabilities
31,933
39,415
41,363
39,206
41,320
Total Current Liabilities
54,010
65,170
67,896
59,952
70,796
Long-Term Debt
852
666
733
534
356
Provision for Risks & Charges
733
562
4,920
4,921
1,205
Deferred Taxes
5,946
8,726
700
3,019
7
Other Liabilities
2,835
3,042
2,931
3,279
2,735
Total Liabilities
64,508
78,433
82,864
71,248
80,531
Common Equity (Total)
146,250
169,550
182,801
209,407
240,750
Total Shareholders' Equity
146,250
169,550
182,801
209,407
240,750
Total Equity
146,250
169,550
182,801
210,252
241,443
Liabilities & Shareholders' Equity
210,758
247,983
265,665
281,500
321,974
Accumulated Minority Interest
-
-
-
845
693

About Sysmex

View Profile
Address
1-5-1 Wakinohama-Kaigandori
Kobe Hyogo 651
Japan
Employees -
Website http://www.sysmex.co.jp
Updated 07/08/2019
Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.